Wang J - Search Results

1

The prognostic value of the controlling nutritional status score in patients with myelodysplastic syndrome.

Qian J, Wang J, Cheng F, Guo HF, Xia J, Zhou X. Qian J, et al. Among authors: wang j. Support Care Cancer. 2022 Nov;30(11):8997-9002. doi: 10.1007/s00520-022-07313-x. Epub 2022 Aug 8. Support Care Cancer. 2022. PMID: 35939237

2

Association between baseline Controlling Nutritional Status score and clinical outcomes of patients with multiple myeloma.

Zhou X, Lu Y, Xia J, Mao J, Wang J, Guo H. Zhou X, et al. Among authors: wang j. Cancer Biomark. 2021;32(1):65-71. doi: 10.3233/CBM-210073. Cancer Biomark. 2021. PMID: 34092619

3

[Clinical Characteristics of Myelodysplastic Syndrome with Patients Chromosome 21 Karyotype Abnormality].

Qian J, Xia J, Xie X, Wang J, Mao JJ, Zhou X. Qian J, et al. Among authors: wang j. Zhongguo Shi Yan Xue Ye Xue Za Zhi. 2021 Oct;29(5):1528-1532. doi: 10.19746/j.cnki.issn.1009-2137.2021.05.024. Zhongguo Shi Yan Xue Ye Xue Za Zhi. 2021. PMID: 34627435 Chinese.

4

[Influence of Chromosome Abnormality on Therapeutic Efficacy and Prognosis of Newly Diagnosed Multiple Myeloma Treated with Bortezomib].

Sun C, Wang J, Guo HF, Zhou X, Shen YF. Sun C, et al. Among authors: wang j. Zhongguo Shi Yan Xue Ye Xue Za Zhi. 2017 Feb;25(1):142-146. doi: 10.7534/j.issn.1009-2137.2017.01.025. Zhongguo Shi Yan Xue Ye Xue Za Zhi. 2017. PMID: 28245391 Chinese.

5

Evaluation of pretreatment red cell distribution width in patients with multiple myeloma.

Wang J, Xie X, Cheng F, Zhou X, Xia J, Qian X, Wang L, Guo H. Wang J, et al. Among authors: wang l. Cancer Biomark. 2017 Sep 7;20(3):267-272. doi: 10.3233/CBM-170032. Cancer Biomark. 2017. PMID: 28826172

6

Early mortality in elderly patients undergoing treatment for multiple myeloma in real-world practice.

Xia J, Wang L, Zhou X, Wang J, Wang H, Guo H. Xia J, et al. Among authors: wang h, wang l, wang j. J Int Med Res. 2018 Jun;46(6):2230-2237. doi: 10.1177/0300060518757640. Epub 2018 Mar 27. J Int Med Res. 2018. PMID: 29584537 Free PMC article.

7

Real-World Clinical Outcomes in Elderly Chinese Patients with Multiple Myeloma: A Single-Center Experience.

Qian X, Chen H, Xia J, Wang J, Zhou X, Guo H. Qian X, et al. Among authors: wang j. Med Sci Monit. 2018 Aug 23;24:5887-5893. doi: 10.12659/MSM.907588. Med Sci Monit. 2018. PMID: 30138301 Free PMC article.

8

Coagulation profiles and thromboembolic events of bortezomib plus thalidomide and dexamethasone therapy in newly diagnosed multiple myeloma.

Shen Y, Zhou X, Wang Z, Yang G, Jiang Y, Sun C, Wang J, Tong Y, Guo H. Shen Y, et al. Among authors: wang z, wang j. Leuk Res. 2011 Feb;35(2):147-51. doi: 10.1016/j.leukres.2010.08.007. Epub 2010 Sep 15. Leuk Res. 2011. PMID: 20832859

9

Short-course bortezomib-based retreatment for patients with multiple myeloma who had received bortezomib-thalidomide-dexamethasone (VTD) as an initial therapy: A single-center case series.

Mao J, Cheng F, Chen H, Wang J, Zhou X, Jiang Y, Zhu Y, Guo H. Mao J, et al. Among authors: wang j. Exp Ther Med. 2014 Apr;7(4):977-981. doi: 10.3892/etm.2014.1496. Epub 2014 Jan 23. Exp Ther Med. 2014. PMID: 24669261 Free PMC article.

10

Clinical utility and patient consideration in the use of lenalidomide for multiple myeloma in Chinese patients.

Wang J, Guo H, Zhou X. Wang J, et al. Onco Targets Ther. 2015 Jun 2;8:1277-84. doi: 10.2147/OTT.S65762. eCollection 2015. Onco Targets Ther. 2015. PMID: 26082645 Free PMC article. Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

220,004 results

Search Page

Filters